title: [Peptide imaging: the somatostatine model].
abstract: Radiolabeled cell-surface peptide receptor-binding molecules are emerging as an important class of radiopharmaceuticals. Main approach has been the use of 111In Octreotide as functional imaging to find NETs. In some tumor types, it is considered the diagnostic gold standard. This article focuses on the current status of peptide-receptor scintigraphy in different tumors, in other oncologic and non oncologic applications and on future developments in these fields.
authors.affiliation: Seconda Universita Napoli, Napoli. mariarosaria.prisco@hotmail.it
authors.forename: Maria Rosaria
authors.initials: MR
authors.lastname: Prisco
authors.forename: Andrea
authors.initials: A
authors.lastname: Vaccaro
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gatta
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin
chemical_list: D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin